Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NIR light-responsive bacteria with live bio-glue coatings for precise colonization in the gut
Meihui Cui, Tao Sun, Shubin Li, et al.
Cell Reports (2021) Vol. 36, Iss. 11, pp. 109690-109690
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field
Xiaotu Ma, Xiaolong Liang, Yao Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 113
Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Jason P. Lynch, Lisa Goers, Cammie F. Lesser
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 772-786
Open Access | Times Cited: 106
Intestinal Delivery of Probiotics: Materials, Strategies, and Applications
Chengcheng Li, Zi‐Xi Wang, Huining Xiao, et al.
Advanced Materials (2024) Vol. 36, Iss. 32
Closed Access | Times Cited: 22
ProbioticEscherichia coliNISSLE 1917 for inflammatory bowel disease applications
Zejing Zhao, Shumin Xu, Wangyang Zhang, et al.
Food & Function (2022) Vol. 13, Iss. 11, pp. 5914-5924
Closed Access | Times Cited: 59
Stability, robustness, and containment: preparing synthetic biology for real-world deployment
Shalni Kumar, Jeff Hasty
Current Opinion in Biotechnology (2023) Vol. 79, pp. 102880-102880
Open Access | Times Cited: 31
Programming the lifestyles of engineered bacteria for cancer therapy
Shengwei Fu, Rongrong Zhang, Yanmei Gao, et al.
National Science Review (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 29
Engineering Escherichia coli Nissle 1917 as a microbial chassis for therapeutic and industrial applications
Mingjing Yu, Shilong Hu, Biao Tang, et al.
Biotechnology Advances (2023) Vol. 67, pp. 108202-108202
Open Access | Times Cited: 29
Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery
Maoyi Li, Nanhui Liu, Jiafei Zhu, et al.
Biomaterials (2024) Vol. 309, pp. 122584-122584
Closed Access | Times Cited: 14
Macroencapsulated bacteria for in vivo sensing and therapeutics
Yidan Lyu, Hao Huang, Yuyan Su, et al.
Matter (2024) Vol. 7, Iss. 4, pp. 1440-1465
Closed Access | Times Cited: 9
Lighting the way: recent developments and applications in molecular optogenetics
Anja Armbruster, Asim ME Mohamed, Hoang Trong Phan, et al.
Current Opinion in Biotechnology (2024) Vol. 87, pp. 103126-103126
Open Access | Times Cited: 9
Genetically Encoded Biosensors for Constrained Biological Functions in Probiotic Escherichia coli Nissle
Shan Jiang, Haofeng Chen, Shiyao Chen, et al.
ACS Synthetic Biology (2025)
Closed Access | Times Cited: 1
Magnetically triggered thermoelectric heterojunctions with an efficient magnetic-thermo-electric energy cascade conversion for synergistic cancer therapy
Yuan Xue, Yong Kang, Ruiyan Li, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases
Haokun Shen, Zitong Zhao, Zengjue Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 594-594
Open Access | Times Cited: 33
A red light-controlled probiotic bio-system for in-situ gut-brain axis regulation
Xinyu Zhang, Gaoju Pang, Tao Sun, et al.
Biomaterials (2023) Vol. 294, pp. 122005-122005
Closed Access | Times Cited: 22
Recent advances on emerging nanomaterials for diagnosis and treatment of inflammatory bowel disease
Wanyue Fu, Lingling Xu, Z Chen, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 149-179
Closed Access | Times Cited: 22
Microbe-material hybrids for therapeutic applications
Meng Chen, Lili Xia, Chenyao Wu, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 16, pp. 8306-8378
Closed Access | Times Cited: 7
Unlocking the potential of optogenetics in microbial applications
Moritz Benisch, Stephanie K. Aoki, Mustafa Khammash
Current Opinion in Microbiology (2023) Vol. 77, pp. 102404-102404
Open Access | Times Cited: 13
Advances of Bacterial Biomaterials for Disease Therapy
Zhai Lin, Laiying Fu, Wei Wei, et al.
ACS Synthetic Biology (2024) Vol. 13, Iss. 5, pp. 1400-1411
Closed Access | Times Cited: 5
Optogenetic Control of Bacterial Expression by Red Light
Elina Multamäki, Andrés García de Fuentes, Oleksii Sieryi, et al.
ACS Synthetic Biology (2022) Vol. 11, Iss. 10, pp. 3354-3367
Open Access | Times Cited: 22
Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment
Yan Huang, Lin Xiaojun, Siyang Yu, et al.
ACS Synthetic Biology (2022) Vol. 11, Iss. 10, pp. 3134-3153
Closed Access | Times Cited: 19
Spatiotemporal Delivery of Dual Nanobodies by Engineered Probiotics to Reverse Tumor Immunosuppression via Targeting Tumor-Derived Exosomes
Shurong Qin, Yuta Liu, Guanzhong He, et al.
ACS Nano (2024) Vol. 18, Iss. 39, pp. 26858-26871
Closed Access | Times Cited: 4
Facile Labeling of Gram-Negative Bacteria with NIR-II Fluorescent Nanoprobes for Intestinal Bacteria Imaging
Wenwen Chen, Rong Chen, Yutong Sun, et al.
ACS Omega (2025) Vol. 10, Iss. 2, pp. 2044-2050
Open Access
Bacterial Autonomous Intelligent Microrobots for Biomedical Applications
Haotian Chen, Yingze Li, Zhenguang Li, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2025) Vol. 17, Iss. 2
Closed Access
Advancement of Engineered Bacteria for Orally Delivered Therapeutics
Peilin Guo, Shuang Wang, Hua Yue, et al.
Small (2023) Vol. 19, Iss. 48
Open Access | Times Cited: 9
Artificially engineered bacteria to treat gastrointestinal disease and cancer
Yong Liu, Wenqin Yu, Qian Wang, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 8, pp. 103667-103667
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top